Author:
Barbieri Beatriz D.,Peeler David J.,Samnuan Karnyart,Day Suzanne,Hu Kai,Sallah Hadijatou J.,Tregoning John S.,McKay Paul F.,Shattock Robin J.
Funder
Horizon 2020 Framework Programme
EU Framework Programme for Research and Innovation Marie Skłodowska-Curie Actions
Engineering and Physical Sciences Research Council
Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada
University College London Hospitals Biomedical Research Centre
Department of Health and Social Care
Reference60 articles.
1. Nanomaterial delivery systems for mRNA vaccines;Buschmann;Vaccines (Basel),2021
2. A new generation of vaccines based on alphavirus self-amplifying RNA;Ballesteros-Briones;Curr. Opin. Virol.,2020
3. Self-amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much lower doses;Vogel;Mol. Ther.,2018
4. COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2;Szubert;EClinicalMedicine,2023
5. Formulation, inflammation and RNA sensing impact the immunogenicity of self-amplifying RNA vaccines;Tregoning;Mol Ther Nucleic Acids,2022